|
|
|
| Home > Our Experience > Phase 1 Experience |
|
For over a decade and half, SIRO has helped the critical transition of a drug from preclinical to clinical stage.
This is a vital step in the drug development process as many licensing deals in the pharmaceutical/ biotech sector
occur during this stage. The value of a potential drug increases dramatically with a successful demonstration of
safety and efficacy in the human population.
At this stage it is critical that you work with a partner that delivers timely, accurate data to enable you to
make decisions about the safety and efficacy of your compound early in the clinical development cycle. The Phase
I group at SIRO has worked with many emerging global pharmaceutical and biotech companies to guide potential drug
candidates into First-in-Human trials and Proof-of-Concept studies. The group also maintains relationships with
specialized Phase I units across the country.
Our services include
- Phase I Studies in Oncology/DM
- Project management
- Feasibility and risk assessments
- Site selection and prequalification
- Clinical and medical monitoring
- Site management
- Recruitment support
- Training for the project team
- Protocol and CRF development
Phase I Project Management and Medical Services Experience
Oncology
- Lung Cancer Study
- Solid Malignant Tumors
- Glioblastoma
- Breast Cancer
- Multiple Myeloma
- Gastric Cancer
Respiratory
Ophthalmology
Urology
- Overactive Bladder
- Neuropathic Bladder
Tropical Diseases
|
|
